 1 Agents affecting nervous system and sensory organs
|
|
 2 Agents affecting individual organs
|
21 Cardiovascular agents
|
211 Cardiotonics
|
212 Antiarrhythmic agents
|
213 Diuretics
|
214 Antihypertensives
|
 2141 Ganglion blockers
|
2142 Hydralazines
|
2143 Rauwolfias
|
2144 Angiotensin converting enzyme inhibitors
|
D00251 Captopril (JP18/USP/INN)
D00621 Enalapril maleate (JP18/USP)
D00362 Lisinopril (USP); Lisinopril hydrate (JP18)
D00624 Perindopril erbumine (JAN/USP)
D00620 Benazepril hydrochloride (JAN/USP)
D00383 Trandolapril (JAN/USP/INN)
D01667 Delapril hydrochloride (JAN/USAN)
D01119 Temocapril hydrochloride (JP18/USAN)
D01549 Imidapril hydrochloride (JP18)
D01900 Alacepril (JP18/INN)
|
2145 Methyldopas
|
2146 Alkaloids
|
2149 Others
|
215 Capillary stabilizers
|
216 Vasoconstrictors
|
217 Vasodilators
|
218 Hyperlipidemia agents
|
219 Miscellaneous
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan